Barry E. Greene, President at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 75,620 shares at $140.43 ($10.8M) on 2018-03-14, disclosed to the SEC on 2018-03-16.
Open-market sale of $10.8M ALNY by President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $140.43 | 2,884 | $405K | 3.7% |
| 2 | $140.43 | 2,884 | $405K | 3.7% |
| 3 | $141.74 | 7,250 | $1.0M | 9.5% |
| 4 | $141.74 | 7,250 | $1.0M | 9.5% |
| 5 | $142.68 | 9,217 | $1.3M | 12.2% |
| 6 | $142.68 | 9,217 |
| $1.3M |
| 12.2% |
| 7 | $143.58 | 8,644 | $1.2M | 11.5% |
| 8 | $143.58 | 8,644 | $1.2M | 11.5% |
| 9 | $144.67 | 9,165 | $1.3M | 12.3% |
| 10 | $144.67 | 9,165 | $1.3M | 12.3% |
| 11 | $145.41 | 1,300 | $189K | 1.7% |
| Total | $143.06 avg | 75,620 | $10.8M | 100% |
| Filing → |
| SAGE | BUY | 2021-06-17 | $496K | — | Filing → |
| ALNY | SELL | 2020-09-11 | $11.0M | — | Filing → |
| ALNY | SELL | 2020-07-09 | $7.1M | — | Filing → |